|
|
Volumn 371, Issue 22, 2014, Pages 2141-2142
|
|
Use of PER977 to reverse the anticoagulant effect of edoxaban
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDOTE;
D DIMER;
EDOXABAN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
PER 977;
PLACEBO;
PROTHROMBIN;
PROTHROMBIN FRAGMENT 1 2;
TISSUE FACTOR PATHWAY INHIBITOR;
UNCLASSIFIED DRUG;
ARGININE;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
HEPARIN ANTAGONIST;
PER977;
PIPERAZINE DERIVATIVE;
PYRIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ANTICOAGULATION;
ARTICLE;
BLOOD CLOTTING TIME;
CONTROLLED CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
DRUG BINDING;
DRUG EFFECT;
DRUG SAFETY;
DYSGEUSIA;
HEADACHE;
HEMOSTASIS;
HOT FLUSH;
HUMAN;
HYDROGEN BOND;
REPRODUCIBILITY;
SCANNING ELECTRON MICROSCOPY;
SINGLE DRUG DOSE;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
BLOOD CLOTTING;
DRUG EFFECTS;
ARGININE;
BLOOD COAGULATION;
FACTOR XA INHIBITORS;
HEPARIN ANTAGONISTS;
HUMANS;
PIPERAZINES;
PYRIDINES;
THIAZOLES;
|
|
EID: 84915821873
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1411800 Document Type: Letter |
|
Times cited : (383)
|
|
References (5)
|
